A detailed history of Breakwater Capital Group transactions in Becton Dickinson & CO stock. As of the latest transaction made, Breakwater Capital Group holds 1,354 shares of BDX stock, worth $321,304. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,354
Previous 1,354 -0.0%
Holding current value
$321,304
Previous $335 Million 5.55%
% of portfolio
0.07%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

SELL
$233.45 - $247.73 $14,007 - $14,863
-60 Reduced 4.24%
1,354 $335 Million
Q4 2023

Jan 23, 2024

SELL
$232.24 - $267.23 $45,054 - $51,842
-194 Reduced 12.06%
1,414 $334 Million
Q3 2023

Nov 03, 2023

BUY
$254.9 - $283.59 $2,803 - $3,119
11 Added 0.69%
1,608 $408 Million
Q2 2023

Jul 24, 2023

BUY
$238.39 - $265.32 $9,535 - $10,612
40 Added 2.57%
1,597 $422 Million
Q1 2023

Apr 26, 2023

BUY
$229.71 - $259.35 $357,658 - $403,807
1,557 New
1,557 $385 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $67.7B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Breakwater Capital Group Portfolio

Follow Breakwater Capital Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Breakwater Capital Group, based on Form 13F filings with the SEC.

News

Stay updated on Breakwater Capital Group with notifications on news.